Patent details

EP4017871 Title: ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY

Basic Information

Publication number:
EP4017871
PCT Application Number:
US2020047339
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207654245
PCT Publication Number:
WO2021035120
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY
French Title of Invention:
ADMINISTRATION DE VECTEUR DE VIRUS ADÉNO-ASSOCIÉ D'ALPHA-SARCOGLYCANE ET TRAITEMENT DE DYSTROPHIE MUSCULAIRE
German Title of Invention:
ADENOASSOZIIERTE VIRUSVEKTORVERABREICHUNG VON ALPHA-SARCOGLYCAN UND BEHANDLUNG VON MUSKELDYSTROPHIE
SPC Number:

Dates

Filing date:
21/08/2020
Grant date:
17/01/2024
EP Publication Date:
29/06/2022
PCT Publication Date:
25/02/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/01/2024
EP B1 Publication Date:
17/01/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/08/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/01/2024
 
 

Name:
Research Institute at Nationwide Children's Hospital
Address:
700 Children's Drive, Room W172,, Columbus, Ohio 43205, United States (US)

Agent

Name:
ARONOVA S.A.
From:
16/04/2024
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
GRIFFIN, Danielle
Address:
United States (US)

2

Name:
RODINO-KLAPAC, Louise
Address:
United States (US)

3

Name:
MENDELL, Jerry, R.
Address:
United States (US)

Priority

1

Priority Number:
201962889749 P
Priority Date:
21/08/2019
Priority Country:
United States (US)

2

Priority Number:
202063014934 P
Priority Date:
24/04/2020
Priority Country:
United States (US)

3

Priority Number:
202063022843 P
Priority Date:
11/05/2020
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/86; C07K 14/47; A61K 48/00;

Publication

European Patent Bulletin

1

Issue number:
202403
Publication date:
17/01/2024
Description:
Grant (B1)

2

Issue number:
202409
Publication date:
28/02/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/09/2025
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/08/2024
Last Annual Fee Paid Number:
5
Last Annual Fee Paid Amount:
52 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
16/04/2024 Power Of Attorney 1
16/04/2024 Outgoing Correspondence 1